난소절제쥐에서 Arginine 첨가 식이가 골밀도 및 골대사에 미치는 영향 = Effects of Arginine Supplementation on Bone Mineral Density and Bone Markers in OVX Rats

다국어 초록 (Multilingual Abstract)

As far as we know, there were no studies of the effect of L-arginine on bone metabolism in post-menopausal women or ovariectomized rats. The primary objective of the current study was to determine whether arginine supplementation was associated with alterations in femoral and spinal bone mineral density (BMD) and bone markers in ovariectomized (Ovx) rats. Forty female Sprague-Dawley rats were divided into two groups, Ovx and sham groups, which were each randomly divided into two subgroups that were fed control and arginine supplemented diet. All rats were fed on experimental diet and deionized water ad libitum for 9 weeks. Bone formation was measured by serum osteocalcin and alkaline phosphatase (ALP) concentrations. Bone resorption was measured by deoxypyridinoline (DPD) crosslinks immunoassay and corrected for creatinine. Serum osteocalcin, growth hormone, insulin-like growth factor-1 (IGF-1), parathyroid hormone (PTH) and calcitonin were analyzed using radioimmunoassay kits. Bone mineral density (BMD) and bone mineral content (BMC) were measured using PIXImus (GE Lunar Co, Wisconsin, USA) in spine and femur. The serum and urine concentrations of Ca and P were determined. The plasma was analyzed for arginine. Diet did not affect weight gain, mean food intake, and plasma arginine concentration. Urinary Ca excretion was decreased by arginine supplementation in Ovx rats, but statistically not significant. The Ovx rats fed arginine-supplemented diet were not significantly different in ALP, osteocalcin, crosslinks value, PTH, calcitonin and IGF-1 compared to those fed control diet. The arginine-supplemented group had significantly higher serum Ca and growth hormone than control group. Spine and femur BMD were significantly increased by arginine supplementation on 5th and 9th weeks after feeding. Our findings indicate that dietary L-arginine supplementation decreased bone mineral density loss in Ovx rats. Therefore, dietary arginine supplementation may represent a potentially useful strategy for the management of osteoporosis.

목차 (Table of Contents)

• ABSTRACT
• 서론
• 연구방법
• 결과
• 고찰
• 요약 및 결론
• 감사의 글
• Literature cited

참고문헌 (Reference)

1 최미자, "콩단백질이 성장기 수컷흰쥐에서 골함량과 골밀도에 미치는 영향" 한국영양학회 35 (35): 409-413, 2002

2 최미자, "콩단백질과 isofalvones가 성장기 암컷 쥐의 골밀도에 미치는 영향" 한국영양학회 36 (36): 359-367, 2003

3 최미자, "콩 단백질과 Isoflavones가 성장기 수컷 흰쥐에서 골 지표와 호르몬에 미치는 영향" 한국영양학회 36 (36): 452-458, 2003

4 최미자, "콩 단백질과 Isoflavones가 성장기 수컷 흰쥐에서 골 지표와 호르몬에 미치는 영향" 한국영양학회 36 (36): 452-458, 2003

5 최미자, "식이 단백질의 종류와 함황아미노산 함량이 성장기 쥐의 골밀도에 미치는 영향" 한국영양학회 37 (37): 100-107, 2004

6 최미자, "성장기 암컷 쥐에서 콩 단백질과 Isoflavones가 골 대사에 미치는 영향" 한국영양학회 36 (36): 549-558, 2003

7 최미자, "성장기 암컷 쥐에서 Arginine 첨가가 골밀도에 미치는 영향" 한국영양학회 40 (40): 235-241, 2007

8 최미자, "성장기 암컷 쥐에서 Arginine 첨가 식이가 골 대사 지표 및호르몬에 미치는 영향" 한국영양학회 40 (40): 320-326, 2007

9 Xing S, "Validation of radioimunoassay for estadiol-17 isotope dilution-mass spectrometry and a test of radiochemical purity" 135 : 189-201, 1983

10 Nanda N, "Two-site immunoradiometricassay(IRMA): detection, efficiency, and procedural modifications" 10 : 225-227, 1994

11 Atkinson C, "The effects of phytoestrogen isoflavones on bone density in women:a double-blind, randomized, placebo-controlled trial" 79 : 326-333, 2004

12 Spence LA, "The effect of soy protein and soy isoflavones on calcium metabolism in postmenopausal women: a randomized crossover study" 81 : 916-922, 2005

13 Dean HJ, "The effect of growth hormone treatment on somatomedin levels in growth hormone deficient children" 55 : 1167-1173, 1982

14 Lee YM, "The effect of dietary taurine supplementation on plasma and urinary free amino acid concentrations in diabetic rats" 526 : 75-82, 2003

15 Choi MJ, "The effect of dietary taurine supplementation on plasma and liver lipid concentrations and free amino acid concentrations in rats fed a high-cholesterol diet" 583 : 235-242, 2006

16 Ho SC, "Soy intake and the maintenance of peak bone mass in Hong Kong Chinese women" 16 : 1363-1369, 2001

17 Sugimoto T, "Serum levels of insulin-like growth factor (IGF) I, IGF binding protein (IGFBP)-2 and IGFBP-3 in osteoporotic patients with and without spinal fractures" 12 : 1272-1279, 1997

18 Kalu DN, "Modulation of age related hyperparathyroidism and senile bone loss in fischer rats by soy protein and food restriction" 122 : 1847-1854, 1998

19 Monson JP, "Influence of growth hormone on accretion of bone mass" 58 (58): 52s-56s, 2000

20 Chyun JH, "Improvement of nitrogen retention by arginine and glycine supplementation and its relation to collagen synthesis in traumatized mature and aged rats" 114 : 1697-1704, 1984

21 Daly JM, "Immune and metabolic effects of arginine in the surgical patient" 208 : 512-523, 1988

22 Krassas GE, "Growth hormone, insulin growth factor-I, and IGF binding protein-3 axis relationship with bone mineral density among healthy men" 49 : 191-199, 2003

23 Andreassen TT, "Growth hormone stimulates bone formation and strength of cortical bone in aged rats" 10 : 1057-1067, 1995

24 Lewinson D, "Growth hormone involvement in the regulation of tartrate resistant acid phosphatase positive cells that are active in cartilage and bone resorption" 52 : 216-221, 1993

25 Lely AJ, "Growth hormone and aging" 9 : 117-119, 1999

26 Barret-Connor E, "Gender differences in insulin-like growth factor and bone mineral density association in old age: the Rancho Bernardo Study" 13 (13): 1343-1349, 1998

27 Sugimoto T, "Effect of low-dose of recombinant human growth hormone on bone metabolism in elderly women with osteoporosis" 147 (147): 339-348, 2002

28 Bravenboer N, "Effect of long-term growth hormone treatment on bone mass and bone metabolism in growth hormone-deficient men" 20 (20): 1778-1784, 2005

29 Greendale GA, "Dietary soy isoflavones and bone mineral density: results from the study of women’s health across the nation" 155 (155): 746-754, 2002

30 Setchell, KD, "Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies" 78 : 593S-609S, 2003

31 Kohli R, "Dietary L-arginine supplementation enhances endothelial nitric oxide synthesis in streptozotocin-induced diabetic rats" 134 (134): 600-608, 2004

32 Mituka BM, "Clinical biochemical and hematological reference value in normal experimental animals and normal humans" Masson 160-, 1987

33 Guarnero P, "Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro" 9 : 692-698, 1994

34 Guarnero P, "Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro" 9 : 692-698, 1994

35 Yvette C. Luiking, "Biomarkers of arginine and lysine excess" 137 : 1662S-1666S, 2007

36 Reeves PG, "AIN-93 purified diets for laboratory rodents" 123 : 1939-1951, 1993